ProfileGDS4459 / ENSG00000233669
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 70% 69% 70% 67% 70% 56% 73% 69% 67% 70% 65% 67% 69% 71% 65% 49% 64% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.2370
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.1569
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.3770
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.1267
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.370
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.656
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.6173
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.2869
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.2367
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.470
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.9465
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.2367
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.2869
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.271
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.0765
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.3649
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.9164